Tenaya Therapeutics, Inc. (TNYA)
Total Valuation
TNYA has a market cap or net worth of $379.23 million. The enterprise value is $287.01 million.
Market Cap | 379.23M |
Enterprise Value | 287.01M |
Important Dates
The last earnings date was Monday, March 18, 2024, after market close.
Earnings Date | Mar 18, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TNYA has 78.52 million shares outstanding. The number of shares has increased by 64.61% in one year.
Shares Outstanding | 78.52M |
Shares Change (YoY) | +64.61% |
Shares Change (QoQ) | +0.65% |
Owned by Insiders (%) | 1.53% |
Owned by Institutions (%) | 77.20% |
Float | 42.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.72 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.09.
Current Ratio | 4.91 |
Quick Ratio | n/a |
Debt / Equity | 0.09 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.90% and return on invested capital (ROIC) is -86.40%.
Return on Equity (ROE) | -69.90% |
Return on Assets (ROA) | -59.80% |
Return on Capital (ROIC) | -86.40% |
Revenue Per Employee | n/a |
Profits Per Employee | -$886,314 |
Employee Count | 140 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +95.15% in the last 52 weeks. The beta is 2.66, so TNYA's price volatility has been higher than the market average.
Beta (1Y) | 2.66 |
52-Week Price Change | +95.15% |
50-Day Moving Average | 5.16 |
200-Day Moving Average | 3.86 |
Relative Strength Index (RSI) | 50.64 |
Average Volume (30 Days) | 630,926 |
Short Selling Information
The latest short interest is 2.55 million, so 3.25% of the outstanding shares have been sold short.
Short Interest | 2.55M |
Short Previous Month | 2.84M |
Short % of Shares Out | 3.25% |
Short % of Float | 5.97% |
Short Ratio (days to cover) | 4.67 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -131.19M |
Pretax Income | -124.08M |
Net Income | -124.08M |
EBITDA | -112.27M |
EBIT | -124.08M |
Earnings Per Share (EPS) | -$1.68 |
Balance Sheet
The company has $104.64 million in cash and $12.42 million in debt, giving a net cash position of $92.22 million or $1.17 per share.
Cash & Cash Equivalents | 104.64M |
Total Debt | 12.42M |
Net Cash | 92.22M |
Net Cash Per Share | $1.17 |
Equity / Book Value | 139.42M |
Book Value Per Share | 1.78 |
Working Capital | 88.85M |
Cash Flow
In the last 12 months, operating cash flow was -$102.07 million and capital expenditures -$1.24 million, giving a free cash flow of -$103.31 million.
Operating Cash Flow | -102.07M |
Capital Expenditures | -1.24M |
Free Cash Flow | -103.31M |
FCF Per Share | -$1.40 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TNYA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -64.61% |
Shareholder Yield | -64.61% |
Earnings Yield | -32.72% |
FCF Yield | -27.24% |
Analyst Forecast
The average price target for TNYA is $15.40, which is 194.46% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $15.40 |
Price Target Difference | 194.46% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |